Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Arylcyclohexylamine

O-DSMT (O-Desmethyltramadol)

C15H23NO2 CAS 80456-81-1 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
O-DSMT (O-Desmethyltramadol)
IUPAC-Name
3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol
CAS-Nummer der Stammverbindung (Referenz)
80456-81-1
Summenformel
C15H23NO2
Molekulargewicht
249.35 g/mol
InChIKey
UWJUQVWARXYRCG-HIFRSBDPSA-N
PubChem
CID 9838803
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
O-Desmethyltramadol ODSMT O DSMT Desmetramadol

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

O-DSMT (O-Desmethyltramadol)

Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor Phenylpropylamine
Geprüfte PubChem- & CAS-Identität C15H23NO2 · CAS 80456-81-1 · CID 9838803
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 249.35 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

μ-Opioid μ-Opioid Receptor 18 nM

Active M1 metabolite of tramadol: (+)-O-DSMT acts as a selective mu-opioid receptor (MOR Ki = 18 nM) agonist (~200x higher MOR affinity than parent tramadol), while (−)-O-DSMT inhibits norepinephrine reuptake (NET), lacking tramadol's parent SERT bottleneck.

Biotransformation & Active Metabolites

Direct active metabolite; inactivated via UGT2B7/1A8 glucuronidation without requiring CYP2D6 activation.

Zeitliche Pharmakokinetik

Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor — Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.

  1. Onset 20–45 min
  2. Peak Window 1.5–3.5 h
  3. Total Window 5–8 h
  4. Residual / Half-Life 4–10 h residual miosis/sedation

Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
10–15 mg
Cognitive & Sensory

Subtle threshold receptor activity (Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
15–30 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
30–55 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
55–85 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
90+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Benzodiazepines (Bromazolam, Etizolam, Clonazolam, Alprazolam)

Profound synergistic respiratory depression and fatal overdose.

Alcohol, GHB/GBL, and Z-drugs

Unconsciousness, respiratory arrest, and fatal pulmonary aspiration.

MAOIs & Potent Stimulants / Dissociatives

NET inhibition plus MAOIs risks hypertensive crisis; dissociatives compound respiratory/aspiration risk.

Hohes Risiko — Vermeiden

Other opioids or Kratom

Additive mu-opioid respiratory depression and unpredictable toxicity threshold.

Vorsicht / Abschwächung

SNRIs / Tricyclics

Additive noradrenergic tachycardia and blood-pressure elevation.

Isomeren- & Strukturvergleich

Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB.

Stabilität & Lagerung

Form: White to off-white crystalline analytical powder (hydrochloride salt). · Freely soluble in water and methanol.

Store dry and sealed at room temperature away from light and moisture.

Cross-Tolerance & Dependence Profile

Cross-tolerant with all mu-opioid agonists. High physical and psychological dependence liability; repeated daily exposure produces classic opioid withdrawal syndrome.

Analytische & toxikologische Monographie

O-DSMT (O-Desmethyltramadol) (3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol; CAS 80456-81-1, PubChem CID 9838803) is a phenylpropylamine reference compound (C15H23NO2, 249.35 g/mol) classified pharmacologically as a Mu-Opioid Receptor Agonist & Norepinephrine Reuptake Inhibitor. Active M1 metabolite of tramadol: (+)-O-DSMT acts as a selective mu-opioid receptor (MOR Ki = 18 nM) agonist (~200x higher MOR affinity than parent tramadol), while (−)-O-DSMT inhibits norepinephrine reuptake (NET), lacking tramadol's parent SERT bottleneck. Direct active metabolite; inactivated via UGT2B7/1A8 glucuronidation without requiring CYP2D6 activation. In published observational and toxicological literature, threshold response is noted at 10–15 mg, light range at 15–30 mg, common reference range at 30–55 mg, strong intensity at 55–85 mg, and heavy/adverse territory at 90+ mg, with an onset of 20–45 min, peak window of 1.5–3.5 h, and total duration of 5–8 h (4–10 h residual miosis/sedation). Only opioid-class compound in our substance catalog; unlike parent tramadol, O-DSMT does not depend on CYP2D6 genetics and has minimal SERT activity, but carries full opioid respiratory depression, rapid physical dependence, and lethal interaction risk with benzodiazepines, alcohol, or GHB. Critical contraindications include Benzodiazepines (Bromazolam, Etizolam, Clonazolam, Alprazolam), Alcohol, GHB/GBL, and Z-drugs, MAOIs & Potent Stimulants / Dissociatives.

Chemische Struktur und Molekülprofil

O-DSMT (O-Desmethyltramadol) (3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) ist eine Referenzverbindung aus der Stoffklasse Arylcyclohexylamine mit der Summenformel C15H23NO2 und einer molaren Masse von 249.35 g/mol. Die Stammverbindung wird unter der CAS-Nummer 80456-81-1 sowie in der NCBI-PubChem-Datenbank unter CID 9838803 geführt (Standard-InChIKey: UWJUQVWARXYRCG-HIFRSBDPSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört O-DSMT (O-Desmethyltramadol) zur chemischen Klasse Phenylpropylamine. Toxikologische Hinweise (PsychonautWiki): moderate potential toxicity relative to its dose due to its potency, potentially lethal when mixed with depressants like alcohol or benzodiazepines. Abhängigkeitspotenzial (PsychonautWiki): mäßiges Abhängigkeitspotenzial bei wiederholter Exposition. Dokumentierte Kreuztoleranz: opioids. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen

Dokumentierte Wechselwirkungen und Kontraindikationen

Ungeklärte Wechselwirkungen (Vorsicht geboten)